OMEX
Odyssey Marine Exploration, Inc.
There isn't enough reported data to score OMEX yet.
RKLB
Rocket Lab USA, Inc.
RKLB lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
OMEX Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Unavailable |
OMEX's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
OMEX PE Valuation
OMEX has no meaningful PE right now: it lost money over the past year.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
OMEX Forward outlook
There aren't enough analyst estimates for OMEX to show an outlook.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
OMEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2024 | -$11.75 | -771% |
| Q1 2024 | -$17.25 | -1250% |
| Q4 2023 | $8.00 | +$41.50 |
| Q3 2023 | $5.25 | +$33.50 |
| Q2 2023 | $1.75 | +$30.75 |
| Q1 2023 | $1.50 | +$27.25 |
| Q4 2022 | -$33.50 | -$14.75 |
| Q3 2022 | -$28.25 | -$4.75 |
RKLB has the stronger earnings trend. Trailing diluted EPS is down 227% for OMEX versus RKLB down 192%.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
OMEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $108.9K | +79% |
| Q2 2026 | $77.9K | -42% |
| Q1 2026 | $22.5K | -83% |
| Q4 2025 | $22.7K | -83% |
| Q3 2025 | $61K | -71% |
| Q2 2025 | $135K | -37% |
| Q1 2025 | $135K | -34% |
| Q4 2024 | $136.1K | -18% |
OMEX's revenue is recovering but still below its 2020 peak: $108,913 last quarter, up 79% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -4006% | -511 points |
| Q2 2026 | -9875% | -6634 points |
| Q1 2026 | -28492% | -26843 points |
| Q4 2025 | -20663% | -19632 points |
| Q3 2025 | -3494% | -2154 points |
| Q2 2025 | -3241% | -1842 points |
| Q1 2025 | -1649% | +674 points |
| Q4 2024 | -1031% | N/A |
OMEX's operating margin was −4006% last quarter, down 511 points from the same quarter a year ago.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over OMEX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB has the edge over OMEX on profitability, with a higher operating margin.
OMEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$4.7M | -$2.7M |
| Q1 2026 | -$3.8M | -$1.9M |
| Q4 2025 | -$2.8M | -$1.1M |
| Q3 2025 | -$2.1M | -$537.7K |
| Q2 2025 | -$2M | -135% |
| Q1 2025 | -$2M | -$182.2K |
| Q4 2024 | -$1.8M | +$432.2K |
| Q3 2024 | -$1.6M | +$295.3K |
OMEX has burned cash in almost every quarter: −$13M over the past year, against −$7M the year before.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has the edge over OMEX on cash flow, with more consistent year-over-year improvement.
OMEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +4.2K shares |
| 1 year | +91% | +1.1M shares |
| 3 years | +195% | +1.6M shares |
| 5 years | +365% | +1.8M shares |
| Available history | +528% | +2M shares |
OMEX has 2M diluted shares, up 91% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2023 | — |
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has the edge over OMEX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
OMEX Net Leverage
OMEX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OMEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.4 | Oversold |
| Stochastic | 7.6 | Oversold |
OMEX's weekly RSI is 28 (oversold) and its Stochastic is 8 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
OMEX PE vs Industrials Sector
| Metric | OMEX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
OMEX has no meaningful PE right now: it lost money over the past year.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
OMEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.1 | 29% below |
| 20 week MA | $17.3 | 42% below |
| 50 week MA | $28.9 | 65% below |
| 100 week MA | $29.9 | 66% below |
| 200 week MA | $57.9 | 83% below |
OMEX is in a downtrend: it's below all five of its weekly moving averages, and 83% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over OMEX on trend strength, trading above more of its moving averages.
OMEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $81.0 | $164.8 | +103% |
| 2021 | $164.8 | $140.0 | -15% |
| 2022 | $140.0 | $82.8 | -41% |
| 2023 | $82.8 | $116.3 | +40% |
| 2024 | $116.3 | $15.7 | -86% |
| 2025 | $15.7 | $53.3 | +239% |
| 2026 YTD | $53.3 | $10.0 | -81% |
OMEX's yearly returns have swung widely, from +239% in 2025 to −86% in 2024. It's down 81% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over OMEX on returns for 2026, with the stronger performance.